Combination of Dipeptidy|peptidase IV Inhibitor (MK-0626) and Cilostazol: The Effect of Anti-Platelet and Anti-Thrombosis in Diabetic Rats

Project: Other project

StatusFinished
Effective start/end date12/20/1212/20/14

Funding

  • Merck Sharp & Dohme Corporation: $24,760.78